Dihydropyridine Calcium Channel Blockers and Risk of Pancreatic Cancer: A Population‐Based Cohort Study

BACKGROUND: Recent studies have reported that dihydropyridine calcium channel blockers (dCCBs) may increase the risk of pancreatic cancer, but these studies had methodological limitations. We thus aimed to determine whether dCCBs are associated with an increased risk of pancreatic cancer compared wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rouette, Julie, McDonald, Emily G., Schuster, Tibor, Brophy, James M., Azoulay, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798809/
https://www.ncbi.nlm.nih.gov/pubmed/36515246
http://dx.doi.org/10.1161/JAHA.122.026789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798809/
https://www.ncbi.nlm.nih.gov/pubmed/36515246
http://dx.doi.org/10.1161/JAHA.122.026789

Ejemplares similares